Policy

Access to Medicines

Ensuring all cancer patients in Europe have access to medicines they need, when they need it.

Europe of Disparities in Cancer Care

Challenging geographical inequalities in European cancer care

Molecular Testing & Personalised Medicine

Raising awareness and driving policy change so the right people get the right treatment at the right time

Biosimilars

Harnessing opportunities for greater patient access to biological cancer medicines.

Immuno-Oncology

Improving outcomes with new cancer treatment modalities

HTA Legislation

Overcoming disparities, reducing barriers to accessing innovative treatment, recognising the true value of new therapies, and improving the sustainability of national healthcare systems

European Partnership for Action Against Cancer (EPAAC)

European collaboration in the fight against cancer

Joint Action on Cancer Control (CanCon)

Harmonising the way we fight cancer in Europe.

iPAAC

Innovative Partnership for Action Against Cancer

Vaccines

Eliminating HPV-related cancers in Europe.

Brexit

Prioritising patients in Brexit negotiations

Right to Be Forgotten

for Cancer Survivors

Cancer Patients’ Rights

Providing every European citizen with the right to the optimum standard of care.

Employment

Recognising employment challenges faced by cancer patients and survivors.

Survivorship

Regaining life satisfaction after cancer treatment is ended

Carers

Finding the right societal response to give people with cancer and their carers a proper quality of life

All.Can

Patient-centred effectiveness of cancer treatments

BenchCan

Benchmarking comprehensive cancer care that provides interdisciplinary treatment for patients, and yield examples of best practice in comprehensive cancer care

Nutrition

Providing information on proper diet and its importance in cancer treatment

Specific Cancers

Bringing awareness to underserved cancer types

JARC

Joint Action on Rare Cancers

EURACAN

European Reference on Rare Adult Solid Cancer.

RARECARENet